Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine Weiner

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The American Journal of Psychiatry|March 4, 2011
Lessons from JimmyElaine Weiner
Men and Masculinities|October 16, 2023
A Missing Piece? Men and the Puzzle of Gender Mainstreaming in the European UnionElaine Weiner
The Lancet. Psychiatry|August 24, 2020
Pharmacological interventions to address cigarette smoking in people with schizophrenia spectrum disordersDaniel J O Roche, Melanie Bennett, Elaine Weiner
Schizophrenia Research|March 8, 2011
Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot studyElaine Weiner, Alison Buchholz, Agnes Coffay, et al.
Schizophrenia Research|June 14, 2008
Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophreniaDeanna L Kelly, Robert P McMahon, Elaine Weiner, et al.
The American Journal of Psychiatry|December 31, 2004
Olanzapine treatment of residual positive and negative symptomsRobert W Buchanan, M Patricia Ball, Elaine Weiner, et al.
Journal of Dual Diagnosis|February 7, 2017
Antipsychotic Treatment and Tobacco Craving in People With SchizophreniaHeidi J Wehring, Stephen J Heishman, Robert P McMahon, et al.
The Journal of Clinical Psychiatry|May 4, 2011
Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysisElaine Weiner, M Patricia Ball, Alison S Buchholz, et al.
Journal of Clinical Psychopharmacology|August 16, 2020
Anti-inflammatory Combination Therapy for the Treatment of SchizophreniaRobert W Buchanan, Elaine Weiner, Deanna L Kelly, et al.
Journal of Clinical Psychopharmacology|June 8, 2017
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Elaine Weiner, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The American Journal of Psychiatry|March 4, 2011
Lessons from JimmyElaine Weiner
Men and Masculinities|October 16, 2023
A Missing Piece? Men and the Puzzle of Gender Mainstreaming in the European UnionElaine Weiner
The Lancet. Psychiatry|August 24, 2020
Pharmacological interventions to address cigarette smoking in people with schizophrenia spectrum disordersDaniel J O Roche, Melanie Bennett, Elaine Weiner
Schizophrenia Research|March 8, 2011
Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot studyElaine Weiner, Alison Buchholz, Agnes Coffay, et al.
Schizophrenia Research|June 14, 2008
Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophreniaDeanna L Kelly, Robert P McMahon, Elaine Weiner, et al.
The American Journal of Psychiatry|December 31, 2004
Olanzapine treatment of residual positive and negative symptomsRobert W Buchanan, M Patricia Ball, Elaine Weiner, et al.
Journal of Dual Diagnosis|February 7, 2017
Antipsychotic Treatment and Tobacco Craving in People With SchizophreniaHeidi J Wehring, Stephen J Heishman, Robert P McMahon, et al.
The Journal of Clinical Psychiatry|May 4, 2011
Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysisElaine Weiner, M Patricia Ball, Alison S Buchholz, et al.
Journal of Clinical Psychopharmacology|August 16, 2020
Anti-inflammatory Combination Therapy for the Treatment of SchizophreniaRobert W Buchanan, Elaine Weiner, Deanna L Kelly, et al.
Journal of Clinical Psychopharmacology|June 8, 2017
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Elaine Weiner, et al.
Pageof 2